How the immune system responds to traumatic injuries
Adaptive Immune Regulation of Traumatic Injury
This study is looking at how serious injuries impact your immune system, especially a special type of immune cell called regulatory T cells, to find out how they help your body heal and reduce inflammation, with the hope of discovering better ways to support recovery after trauma.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10854973 on NIH RePORTER |
What this research studies
This research investigates how traumatic injuries affect the immune system, particularly focusing on a type of immune cell called regulatory T cells (Tregs). It aims to understand how these cells are activated by trauma and how they help restore balance in the immune response. By studying the mechanisms of Treg activation and their role in controlling inflammation, the research seeks to identify ways to improve patient outcomes after traumatic injuries. The findings could lead to new therapeutic strategies that enhance immune function and reduce complications associated with trauma.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced traumatic injuries and may be at risk for complications like infections or systemic inflammatory response syndrome.
Not a fit: Patients with non-traumatic conditions or those who do not have a significant immune response to injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments that enhance immune responses in patients recovering from traumatic injuries.
How similar studies have performed: Previous research has shown promising results in understanding immune responses to trauma, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Lederer, James a. — Brigham and Women's Hospital
- Study coordinator: Lederer, James a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.